Conformational detection of prion protein with biarsenical labeling and FlAsH fluorescence

被引:31
作者
Coleman, Bradley M.
Nisbet, Rebecca M. [2 ,3 ]
Han, Sen [2 ,3 ]
Cappai, Roberto [2 ,3 ]
Hatters, Danny M. [2 ,3 ]
Hill, Andrew F. [1 ,2 ,3 ]
机构
[1] Univ Melbourne, Mol Sci & Biotechnol Inst Bio21, Dept Biochem & Mol Biol, Parkville, Vic 3010, Australia
[2] Univ Melbourne, Dept Pathol, Parkville, Vic 3010, Australia
[3] Univ Melbourne, Mental Hlth Res Inst, Parkville, Vic 3010, Australia
基金
澳大利亚国家健康与医学研究理事会;
关键词
Prion; Protein folding; PrP; Fluorescence; BLOOD-TRANSFUSION; PRP; TRANSMISSION; CONVERSION; BSE; REPLICATION; FEATURES;
D O I
10.1016/j.bbrc.2009.01.120
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Prion diseases are associated with the misfolding of the host-encoded cellular prion protein (PrPC) into a disease associated form (PrPSc). Recombinant PrP can be refolded into either an alpha-helical rich conformation (alpha-PrP) resembling PrPC or a P-sheet rich. protease resistant form similar to PrPSc. Here, we generated tetracysteine tagged recombinant PrP, folded this into alpha- or beta-PrP and determined the levels of FlAsH fluorescence. Insertion of the tetracysteine tag at three different sites within the 91-111 epitope readily distinguished beta-PrP from alpha-PrP upon FlAsH labeling. Labelling of tetracysteine tagged PrP in the alpha-helical form showed minimal fluorescence, whereas labeling of tagged PrP in the beta-sheet form showed high fluorescence indicating that this region is exposed upon conversion. This highlights a region of PrP that can be implicated in the development of diagnostics and is a novel, protease free mechanism for distinguishing PrPSc from PrPC. This technique may also be applied to any protein that undergoes conformational change and/or misfolding Such as those involved in other neurodegenerative disorders including Alzheimer's, Huntington's and Parkinson's diseases. (C) 2009 Elsevier Inc. All rights reserved.
引用
收藏
页码:564 / 568
页数:5
相关论文
共 29 条
[1]   Delineating common molecular mechanisms in Alzheimer's and prion diseases [J].
Barnham, Kevin J. ;
Cappai, Roberto ;
Beyreuther, Konrad ;
Masters, Colin L. ;
Hill, Andrew F. .
TRENDS IN BIOCHEMICAL SCIENCES, 2006, 31 (08) :465-472
[2]   Folding of prion protein to its native α-helical conformation is under kinetic control [J].
Baskakov, IV ;
Legname, G ;
Prusiner, SB ;
Cohen, FE .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (23) :19687-19690
[3]   GFP-tagged PrP supports compromised prion replication in transgenic mice [J].
Bian, JF ;
Nazor, KE ;
Angers, R ;
Jernigan, M ;
Seward, T ;
Centers, A ;
Green, M ;
Telling, GC .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 340 (03) :894-900
[4]   In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrPSc [J].
Bocharova, OV ;
Breydo, L ;
Parfenov, AS ;
Salnikov, VV ;
Baskakov, IV .
JOURNAL OF MOLECULAR BIOLOGY, 2005, 346 (02) :645-659
[5]  
Dolan G, 2006, HAEMOPHILIA, V12, P26
[6]   Specific covalent labeling of recombinant protein molecules inside live cells [J].
Griffin, BA ;
Adams, SR ;
Tsien, RY .
SCIENCE, 1998, 281 (5374) :269-272
[7]   Anterograde and retrograde intracellular trafficking of fluorescent cellular prion protein [J].
Hachiya, NS ;
Watanabe, K ;
Yamada, M ;
Sakasegawa, Y ;
Kaneko, K .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (04) :802-807
[8]   Species-barrier-independent prion replication in apparently resistant species [J].
Hill, AF ;
Joiner, S ;
Linehan, J ;
Desbruslais, M ;
Lantos, PL ;
Collinge, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (18) :10248-10253
[9]   Transmission of BSE by blood transfusion in sheep [J].
Houston, F ;
Foster, JD ;
Chong, A ;
Hunter, N ;
Bostock, CJ .
LANCET, 2000, 356 (9234) :999-1000
[10]   Variant Creutzfeldt-Jakob disease: risk of transmission by blood transfusion and blood therapies [J].
Ironside, JW .
HAEMOPHILIA, 2006, 12 :8-15